Understanding high-risk COPD: Analysis of real-world data to investigate characteristics and outcomes in patients with high-risk COPD. (OPRI 2306: High Risk COPD)

Study identification

• EU PAS number:
  EUPAS107087
• Study ID:
  107088
• Official title and acronym:
  Understanding high-risk COPD: Analysis of real-world data to investigate characteristics and outcomes in patients with high-risk COPD. (OPRI 2306: High Risk COPD)
• DARWIN EU® study:
  No
• Study countries:
  Australia

  United Kingdom
• Study description:
  This project will investigate the patient characteristics, treatments and comorbidities that are associated with patients with a high risk of COPD and worsening symptoms.
• Study status:
  Ongoing

Research institutions and networks

Institutions

Observational & Pragmatic Research Institute Pte (OPRI)

United Kingdom

Networks

Optimum Patient Care (OPC) Network

United Kingdom (Northern Ireland)

Study timelines

Date when funding contract was signed

Actual: 09/10/2023

Study start date

Actual: 09/10/2023

Data analysis start date

Actual: 09/10/2023

Date of final study report

Planned: 13/10/2025

Sources of funding

Other

More details on funding

OPC

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable